Dr. Alan Venook is the Madden Family Distinguished Professor of Medical Oncology and Translational Research at the University of California, San Francisco (UCSF) and is the Shorenstein Associate Director for Program Development at the Helen Diller Family Comprehensive Cancer Center at UCSF. Dr. Venook received a BA in Biological Sciences from Rutgers College in 1976, his MD Degree in 1980 from UCSF, completed his internship at UCSF in 1981and then spent two years in the Public Health Service. He completed residency in Internal Medicine at the University of California, Davis and then returned to UCSF as a Hematology / Oncology Fellow in 1985, joining the faculty in 1988.
Dr. Venook’s initial clinical research projects involved multidisciplinary collaborations to treat tumors via the hepatic artery. In 1990 he described the UCSF experience with chemoembolization for patients with hepatocellular carcinoma (in JCO) and then in 1995 demonstrated excellent outcomes in patients with HCC undergoing liver transplant. He served as the founding Chair of the National Cancer Institute’s Hepatobiliary Task Force from 2006-2010. He both chaired the GI Committee of the Alliance for Clinical Trials in Oncology (formerly CALGB) and was an Associate Editor of the Journal of Clinical Oncology since 2010 before recently stepping down to assume new responsibilities at UCSF.
Dr. Venook has chaired and/or authored six major studies within the cooperative groups including the original organ dysfunction studies and, most recently has focused on colorectal cancer, presenting the results of CALGB/SWOG 80405 at ASCO, 2014.